Allinaire Therapeutics logo — Developing novel therapeutics for cardiopulmonary diseases

Allinaire Therapeutics

Developing novel therapeutics for cardiopulmonary diseases

Founded 2016 United States Beachwood, United States 3 employees Seed Total: $1.57M Biotechnology, Health Care +1

General Information

Company Name Allinaire Therapeutics
Founded Year 2016
Location United States Beachwood, United States
Employees 3
Industries Biotechnology, Health Care, Health and Wellness
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Allinaire Therapeutics. To contact Allinaire Therapeutics, visit allinaire.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Allinaire Therapeutics compare?

A PDF of Allinaire Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Allinaire Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Allinaire Therapeutics

Allinaire Therapeutics is a biotechnology startup founded in 2016, with a focus on developing novel therapeutics for cardiopulmonary diseases. The company has received $1.57M in a Seed Round investment on 27 January 2017 from notable investors including IU Ventures, BioCrossroads, and BioMotiv. Headquartered in the United States, Allinaire Therapeutics operates within the Biotechnology and Health Care industries. With this recent investment, the company is poised to advance its research and development efforts in the field of cardiopulmonary therapeutics, attracting attention from potential venture capital firms interested in the biotech and healthcare sectors.

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $1.57M 3
IU Ventures, BioCrossroads +1
27 Jan 2017

Allinaire Therapeutics Alternatives & Competitors

View All Alternatives
Allinaire Therapeutics vs
AltruBio Inc.
AltruBio Inc. United States

Novel Therapeutics for Immunological Diseases

Series B
28 employees
Biotechnology, Health Care
Allinaire Therapeutics vs
Nobias Therapeutics
Nobias Therapeutics United States

Clinical-stage company developing novel small molecule therapeutics for rare diseases

Series A
12 employees
Health Care, Health and Wellness
Allinaire Therapeutics vs

Developing novel mRNA-based therapeutics

Seed
11 employees
Biotechnology, Health Care

FAQ About Allinaire Therapeutics

Developing novel therapeutics for cardiopulmonary diseases
Allinaire Therapeutics was founded in 2016.
Allinaire Therapeutics is headquartered in Beachwood, United States.
Allinaire Therapeutics operates in Biotechnology, Health Care and Health and Wellness.
Allinaire Therapeutics has approximately 3 employees.
Allinaire Therapeutics has completed 1 funding round, raising a total of $1.57M. The latest funding stage is Seed.
Top alternatives and competitors to Allinaire Therapeutics include AltruBio Inc., Nobias Therapeutics, Pantherna Therapeutics GmbH, Vixiar Medical, Innoskel. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Allinaire Therapeutics and AltruBio Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Allinaire Therapeutics, https://bouncewatch.com/company/allinaire-therapeutics, updated 24 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes